More Globe Newswire

View Older Stories View Newer Stories

Jul 10, 2024 08:05AM Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With N
Jul 10, 2024 08:05AM Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders Wi
Jul 10, 2024 08:04AM Sezzle’s BNPL Solution Now Available at Heritage Grocers Group Stores
Jul 10, 2024 08:01AM Sunrun Announces Date for Second Quarter 2024 Earnings Report
Jul 10, 2024 08:00AM New poll finds that half of Canadians are concerned about generative artificial intelligence and the spread of misinformation
Jul 10, 2024 08:00AM Santa Barbara County Selects Genasys for Emergency Response Planning and Evacuation Management
Jul 10, 2024 08:00AM Greenridge Exploration Undertakes Extensive Exploration Program on its Carpenter Lake Project in Preparation of the Upcoming Drill Season and Increases Marketing Budget
Jul 10, 2024 08:00AM No cottage? No problem. Make Evergreen Brick Works your place this summer
Jul 10, 2024 08:00AM Ocular Therapeutix™ Announces Late-Breaking Abstract of HELIOS Study to be Presented at 42nd ASRS Annual Scientific Meeting
Jul 10, 2024 08:00AM Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
Jul 10, 2024 08:00AM Tr1X Announces First Patient Dosed in Proof of Concept GvHD Trial Evaluating TRX103, a First-in-Class Type 1 Treg (Tr1) Cell Therapy
Jul 10, 2024 08:00AM Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns
Jul 10, 2024 08:00AM Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
Jul 10, 2024 08:00AM CRN Honors Infinidat’s Eric Herzog as a 2024 Inclusive Channel Leader
Jul 10, 2024 08:00AM Adverum Biotechnologies to Host Webcast to Review Clinical Data from the 26-Week Interim Analysis of the Ongoing LUNA Phase 2 Trial in Wet AMD Being Presented at ASRS Annual Meeting
Jul 10, 2024 08:00AM Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
Jul 10, 2024 08:00AM Syntec Optics (Nasdaq: OPTX) Builds Higher Volume Manufacturing Cells for Low Earth Orbit Satellite Optics and Data Center Optical Connectivity Product Lines
Jul 10, 2024 08:00AM Momcozy Earns Two Dozen Product Awards in 2024, Solidifying its Position as a Smart Option for Mothers Across the World
Jul 10, 2024 08:00AM Horizon Aircraft Appoints Phil Kelly as Senior Vice President Business Development
Jul 10, 2024 08:00AM ACAMS Opens Pre-Registration for New Certified Anti-Fraud Specialist (CAFS) Certification to Combat Fast-Growing Global Fraud Threats
Jul 10, 2024 08:00AM Applied Digital Announces Appointment of Industry-Leader Chris Jackson as Senior Vice President of Operations
Jul 10, 2024 08:00AM International Land Alliance Announces First Quarter Results
Jul 10, 2024 08:00AM Gaxos Partners with Meshy to Deliver AI-Generated 3D Models in its Product for Game Developers and Publishers
Jul 10, 2024 08:00AM eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
Jul 10, 2024 08:00AM CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
Jul 10, 2024 08:00AM Heidelberg Materials North America Encourages Participation in the Sixth Edition of the Quarry Life Award
Jul 10, 2024 08:00AM Gov. Glenn Youngkin Appoints Virginia Credit Union’s Cherry Dale to Virginia Council on Women
Jul 10, 2024 08:00AM Santa Barbara County Selects Genasys for Emergency Response Planning and Evacuation Management
Jul 10, 2024 08:00AM Noah Basketball and the Joe Gibbs Human Performance Institute Partner to Unlock the Power of Big Data and Biomechanics
Jul 10, 2024 08:00AM Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB
Jul 10, 2024 08:00AM Spectaire Unveils AireCore 2.0: Opening New Revenue Opportunities in Pharmaceuticals, Environmental Analysis, and Advanced Materials Research
Jul 10, 2024 08:00AM Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
Jul 10, 2024 08:00AM Rush Street Interactive Announces Second Quarter 2024 Earnings Release Date
Jul 10, 2024 08:00AM Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model
Jul 10, 2024 08:00AM nuVizz Recognized in the 2024 Gartner® Market Guide for Last-Mile Delivery Technology Report
Jul 10, 2024 08:00AM Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
Jul 10, 2024 08:00AM Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
Jul 10, 2024 08:00AM Whitestone REIT Announces Second Quarter 2024 Earnings Webcast and Conference Call
Jul 10, 2024 07:59AM Danske Bank A/S, transactions by persons discharging managerial responsibilities
Jul 10, 2024 07:59AM COMPASS SELF STORAGE OPENS STATE-OF-THE-ART STORAGE CENTER IN EAGLE LAKE, FLORIDA
Jul 10, 2024 07:55AM EARLY WARNING NEWS RELEASE
Jul 10, 2024 07:55AM VelocityEHS Invents Game-Changing 3D Ergonomics Assessments Using AI & Machine Learning
Jul 10, 2024 07:55AM VelocityEHS Invents Game-Changing 3D Ergonomics Assessments Using AI & Machine Learning
Jul 10, 2024 07:45AM Golden Sky Identifies New Geophysical Targets and Expands the Rayfield Copper-Gold Property to ~50,800-hectares, South-Central British Columbia
Jul 10, 2024 07:42AM Alliance Trust Plc - Net Asset Value
Jul 10, 2024 07:31AM nCino Named a 2024 World’s Top FinTech Company by CNBC
Jul 10, 2024 07:30AM Netcompany - Transactions in connection with share buyback programme
Jul 10, 2024 07:30AM Abcourt Produces 327.6 Ounces of Gold from 1,428 Tonnes Grading 7.4 g/t Au at the Sleeping Giant Mine for the Quarter ended June 30, 2024
Jul 10, 2024 07:30AM First Helium Summarizes High Impact Exploration Targets and Corporate Actions for H2 2024
Jul 10, 2024 07:30AM Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
View Newer Stories View Older Stories